BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17622112)

  • 21. Individual and interacting effects of formulation variables on the tensile strength and microbial survival in diclofenac tablets.
    Ayorinde JO; Itiola OA
    Arch Pharm Res; 2010 Mar; 33(3):395-403. PubMed ID: 20361304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formulation and evaluation of dried yeast tablets using different techniques.
    Al-Mohizea AM; Ahmed MO; Al-jenoobi FI; Mahrous GM; Abdel-Rahman AA
    Eur J Pharm Biopharm; 2007 Aug; 67(1):253-9. PubMed ID: 17270410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of methacrylic acid and hydroxypropylmethyl cellulose on the tablet properties and in vitro release of dextromethorphan hydrobromide.
    Takka S; Singh Bharaj S; Sakr A
    Pharmazie; 2003 Dec; 58(12):886-90. PubMed ID: 14703967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of mini-tablets with 1mm and 2mm diameter.
    Tissen C; Woertz K; Breitkreutz J; Kleinebudde P
    Int J Pharm; 2011 Sep; 416(1):164-70. PubMed ID: 21726616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimization of poorly compactable drug tablets manufactured by direct compression using the mixture experimental design.
    Martinello T; Kaneko TM; Velasco MV; Taqueda ME; Consiglieri VO
    Int J Pharm; 2006 Sep; 322(1-2):87-95. PubMed ID: 16806756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The use of semi-synthetic polymers in the formulation of sucking and chewable tablets containing sage extract and zinc gluconate].
    Linka WA; Golenia E; Zgoda MM; Kołodziejczyk MK
    Polim Med; 2014; 44(4):237-45. PubMed ID: 25932905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of Albizia zygia gum as a binding agent in tablet formulations.
    Odeku OA
    Acta Pharm; 2005 Sep; 55(3):263-76. PubMed ID: 16375837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naproxen-Eudragit microspheres: screening of process and formulation variables for the preparation of extended release tablets.
    Zaghloul AA; Faltinek J; Vaithiyalingam SR; Reddy IK; Khan MA
    Pharmazie; 2001 Apr; 56(4):321-4. PubMed ID: 11338673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of fluid bed formulations of metoprolol granules and tablets using an experimental design.
    Tomuţă I; Alecu C; Rus LL; Leuçuta SE
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1072-81. PubMed ID: 19353417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a controlled release formulation by continuous twin screw granulation: Influence of process and formulation parameters.
    Vanhoorne V; Vanbillemont B; Vercruysse J; De Leersnyder F; Gomes P; Beer TD; Remon JP; Vervaet C
    Int J Pharm; 2016 May; 505(1-2):61-8. PubMed ID: 27041123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of properties of tablets and energy profile of compaction of two spray-dried lactoses.
    Muzíková J; Sináglová P
    Acta Pol Pharm; 2013; 70(1):129-35. PubMed ID: 23610968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some compaction characteristics of the hot water leaf extract og Nauclea latifiola: a potential antimalarial agent.
    Emeje MO; Isimi CY; Oqua DA; Kunle OO
    J Herb Pharmacother; 2005; 5(4):23-30. PubMed ID: 16635965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An innovative floating gastro retentive dosage system: formulation and in vitro evaluation.
    Sauzet C; Claeys-Bruno M; Nicolas M; Kister J; Piccerelle P; Prinderre P
    Int J Pharm; 2009 Aug; 378(1-2):23-9. PubMed ID: 19465095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study on moisture isotherms of formulations: the use of polynomial equations to predict the moisture isotherms of tablet products.
    Li Y; Sanzgiri YD; Chen Y
    AAPS PharmSciTech; 2003 Dec; 4(4):E59. PubMed ID: 15198554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of starch 1500 as a binder and disintegrant in lamivudine tablets prepared by high shear wet granulation.
    Rahman BM; Ibne-Wahed MI; Khondkar P; Ahmed M; Islam R; Barman RK; Islam MA
    Pak J Pharm Sci; 2008 Oct; 21(4):455-9. PubMed ID: 18930870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roll compaction of mannitol: compactability study of crystalline and spray-dried grades.
    Wagner CM; Pein M; Breitkreutz J
    Int J Pharm; 2013 Sep; 453(2):416-22. PubMed ID: 23742975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of powder characteristics on oral tablet disintegration.
    Yamamoto Y; Fujii M; Watanabe K; Tsukamoto M; Shibata Y; Kondoh M; Watanabe Y
    Int J Pharm; 2009 Jan; 365(1-2):116-20. PubMed ID: 18804156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of cellulose II powders as a potential multifunctional excipient in tablet formulations.
    de la Luz Reus Medina M; Kumar V
    Int J Pharm; 2006 Sep; 322(1-2):31-5. PubMed ID: 16828996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of chitosan on the stability and morphological parameters of tablets with Epilobium parviflorum Schreb. extract.
    Marczyński Z; Bodek KH
    Polim Med; 2007; 37(3):3-11. PubMed ID: 18251200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.